BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22903294)

  • 1. Bilateral ulna fractures associated with bisphosphonate therapy.
    Ang BF; Koh JS; Ng AC; Howe TS
    Osteoporos Int; 2013 Apr; 24(4):1523-5. PubMed ID: 22903294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Murray JC; Audet MC; Bédard M; Michou L
    Osteoporos Int; 2016 Feb; 27(2):833-6. PubMed ID: 26556740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress fracture of the ulna associated with bisphosphonate therapy and use of walking aid.
    Chiang GS; Koh KW; Chong TW; Tan BY
    Osteoporos Int; 2014 Aug; 25(8):2151-4. PubMed ID: 24833031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical femoral fractures bilaterally in a patient receiving denosumab.
    Drampalos E; Skarpas G; Barbounakis N; Michos I
    Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
    [No Abstract]   [Full Text] [Related]  

  • 5. Ulnar fractures with bisphosphonate therapy: a systematic review of published case reports.
    Tan SH; Saseendar S; Tan BH; Pawaskar A; Kumar VP
    Osteoporos Int; 2015 Feb; 26(2):421-9. PubMed ID: 25227921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical fracture of the ulna associated with alendronate use.
    Bjørgul K; Reigstad A
    Acta Orthop; 2011 Dec; 82(6):761-3. PubMed ID: 22066557
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
    Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
    Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
    [No Abstract]   [Full Text] [Related]  

  • 8. Alendronate-associated ulnar and tibial fractures: a case report.
    Tang ZH; Kumar VP
    J Orthop Surg (Hong Kong); 2011 Dec; 19(3):370-2. PubMed ID: 22184174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Atypical Ulnar Fracture is Associated with Bisphosphonate Therapy and Severe Spinal Deformity: A Case Report.
    Okamoto M; Kashii M; Abe S
    J Hand Surg Asian Pac Vol; 2022 Jun; 27(3):553-559. PubMed ID: 35808877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical ulnar fracture associated with long-term bisphosphonate use.
    Osada R; Zukawa M; Kimura T
    J Orthop Sci; 2015 Nov; 20(6):1132-5. PubMed ID: 24878550
    [No Abstract]   [Full Text] [Related]  

  • 11. Signs of Insufficiency Fractures Overlooked in a Patient Receiving Chronic Bisphosphonate Therapy.
    Shaikh W; Morris D; Morris S
    J Am Board Fam Med; 2016; 29(3):404-7. PubMed ID: 27170798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
    Asano Y; Tajiri K; Yagishita S; Nakanishi H; Ishii T
    Osteoporos Int; 2020 Dec; 31(12):2473-2476. PubMed ID: 32910217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of bilateral atypical femoral fractures associated with the sequential use of teriparatide and denosumab: a case report.
    Ramchand SK; Chiang CY; Zebaze RM; Seeman E
    Osteoporos Int; 2016 Feb; 27(2):821-5. PubMed ID: 26458389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
    Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review.
    Fink HA; MacDonald R; Forte ML; Rosebush CE; Ensrud KE; Schousboe JT; Nelson VA; Ullman K; Butler M; Olson CM; Taylor BC; Brasure M; Wilt TJ
    Ann Intern Med; 2019 Jul; 171(1):37-50. PubMed ID: 31009947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
    Puah KL; Tan MH
    Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
    [No Abstract]   [Full Text] [Related]  

  • 19. Bisphosphonate fractures as a cause of painful total hip arthroplasty.
    Curtin BM; Fehring TK
    Orthopedics; 2011 Dec; 34(12):e939-44. PubMed ID: 22146214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
    Sánchez A; Blanco R
    Osteoporos Int; 2017 Mar; 28(3):1145-1147. PubMed ID: 27866217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.